The global immunoassay market size reached USD 39.72 Billion in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period, according to latest analysis by Emergen Research. Increase in prevalence of chronic and infectious diseases is a major factor driving market revenue growth. According to the International Diabetes Federation (IDF), in 2021 approximately 537 million were living with diabetes worldwide and the number is estimated to rise to 643 million by 2030. Immunoassays are often used in diabetology to measure HbA1c, C-peptide, insulin, and beta cell autoantibodies, which are vital indicators for diagnosis and categorization of diabetes mellitus. Important indicators for precise classification of type 1, type 2, and other specialized kinds of diabetes include autoantibodies against beta cell constituents.
The constant efforts of prominent players to develop newer and modern technologies and product advancements are expected to drive the growth of the industry over the coming years. The report studies the extensive business expansion plans and advancements in R&D activities and product portfolio. The report offers a clear understanding of the alliances in the market, such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches and brand promotions, and corporate deals.
Competitive Outlook: The leading companies operating in the Immunoassay market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Top Companies Operating in the Immunoassay Market and Profiled in the Report are:
Siemens Healthcare GmbH, Biomérieux, Abbott, Becton Dickinson and Company, Beckman Coulter, Inc., Hologic, Inc., Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific
Objectives of the Report:
Study of the global Immunoassay market size by key regions, types, and applications with reference to historical data (2017-2018) and forecast (2020-2027)
Industrial structure analysis of the Immunoassay market by identification of various sub-segments
Extensive analysis of key market players along with their SWOT analysis
Competitive landscape benchmarking
Analysis of Immunoassay market based on growth trends, futuristic outlook, and contribution to the total growth of the market
Analysis of drivers, constraints, opportunities, challenges, and risks in the global Immunoassay market
Comprehensive analysis of competitive developments such as expansions, agreements, new product launches, and other strategic alliances
Thank you for reading our report. For further queries regarding the report or customization options, please connect with us. Our team will ensure you get a report well-suited to your needs.
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
